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While artemisinin is known as anticancer medication with favorable remedial effects, its side effects must not be
neglected. In order to reduce such side effects and increase artemisinin therapeutic index, nano technology has
been considered as a new approach. Liposome preparation is supposed to be one of the new methods of drug
delivery. To prepare the desired nanoliposome, certain proportions of phosphatidylcholine, cholesterol and
artemisinin are mixed together. Besides, in order to achieve more stability, the formulation was pegylated by
polyethylene glycol 2000 (PEG 2000). Mean diameter of nanoliposomes was determined by means of Zeta sizer.
Encapsulation was calculated 96.02% in nanoliposomal and 91.62% in pegylated formulation. Compared to
pegylated formulation, the percent of released drug in nanoliposomal formulation was more. In addition, this study
reveals that cytotoxicity effect of pegylated nanoliposomal artemisinin was more than nanoliposomal artemisinin.
Since artificial neural network shows high possibility of nonlinear modulation, it is used to predict cytotoxicity effect
in this study, which can precisely indicate the cytotoxicity and IC50 of anticancer drugs.
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While cancer is known to be one of the widespread dis-
eases all around the world, breast cancer is considered
to be the commonest type- 18% of all (Warner 2011; Vo
and Millis 2012). Artemisinin, which is a terpene lactone
taken from the leaves of Artemisia annua, is used as anti
cancer drug (Yatuv et al. 2010; Lai and Singh 2006). Ar-
temisinin molecule can damage the molecule and finally
lead to the death of the cell (Lai and Singh 2006; Chen
et al. 2009). However, what is not to be neglected is its
side effects Chadwick et al. (2009). It seems practical to
use nanocarriers in order to improve efficiency and pac-
litaxel toxic pattern. One of the controversial issues in
nanotherapy concerns reduction or elimination of its
side effects. Nanocarriers are used in nanotechnology as
pioneer ones Peer et al. (2007). In this study liposomes
are used as lipid nanocarriers Riaz (1996).* Correspondence: s.ebrahimalavi@gmail.com; maedehkoohi@gmail.com
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in any medium, provided the original work is pThe Radial Basis Function (RBF) neural network me-
thodology and the fuzzy means training strategy used for
developing QSTR predictors of toxicity to Vibrio fischeri
for a heterogeneous set of compounds (Georgia Melagraki
et al. 2006). Industrial and municipal wastewaters consti-
tute major sources of contamination of the aquatic com-
partment and represent a threat to aquatic life. Artificial
neural networks based on three different learning para-
digms were studied as a means of predicting acute toxicity
to trout (Gagné and Blaise 1997). An artificial neural net-
work in quantitative structure–activity relationship
(QSAR) was developed for modeling of cytotoxicity data
for anti-HIV 5-pheny-l-phenylamino-1H-imidazole deri-
vatives. The obtained results show the validity of proposed
model in the prediction of cytotoxity data of correspon-
ding anti-HIV drugs (M. Arab Chamjangali et al. 2007).
Mathematical methods can be used to anticipate the
amount of cytotoxicity and IC50 of either formulation.
The aim of the study is liposome preparation and
pegylation of artemisinin to gain improved therapeuticn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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xicity and IC50 both of these formulations.Materials and methods
Materials
Artemisinin, phosphatidylcholine, cholesterol, polyethyl-
ene glycol 2000 (PEG 2000) and MTT (0.5 mg/ml) reso-
lution was purchased from Sigma Co. Besides,
Invitrogen Co. Ethanol and isopropanol and RPMI 1640
medium were purchased from Merck Co. and Invitrogen
Co., respectively. Also breast cancer cell line (MCF-7)
was obtained from Pasteur Institute, Iran.Nanoliposomal and pegylated drug preparation
Cholesterol and phosphatidylcholine (ratio of 1 to 13.5)
was dissolved in 100 ml of 98% ethanol (400 rpm, room
temperature). Then 1 mg of artemisinin was added to
the suspension and mixed by means of magnetic stirrer
(300 rpm, 15 min, room temperature). After that, the
solvent phase was evaporated by means of rotary evapo-
rator (Heidolph Co., Germany) and the obtained gelos
was dissolved in 12 ml of physiologic serum. In order to
prepare pegylated nanoliposomal artemisinin some extra
PEG 2000 was also added. Then the formulations are
sonicated for 5 minutes (Bandelin Sonorex Digitec,
60 Hz).Size measurement of nanoliposomes
Nanoliposomes mean diameter was determined by Zeta
sizer device (Malvern Instruments Ltd).Figure 1 Laboratory data for cytotoxicity of nanoliposomal artemisin
cancer treatment.Encapsulation efficiency
Equal volumes of prepared solutions were centrifuged
(13000 rpm, 30 min, 4°C) in order to study the amount
of paclitaxel encapsulated in both nanoliposomal and
pegylated nanoliposomal formulations. Then, spectro-
photometer (UV-1601 PC, Shimadzu Co.) was used to
determine supernatant optical absorption of each formu-
lation at wavelength of 195 nm. Formula 1 was used for
calculation of the encapsulation (Zhang and Feng 2006).
Encapsulation Efficiency%
¼ actual amount of drug loaded in nanoparticles




After MCF-7 cellular culture, 100 μl of the suspension
containing 10000 cells was poured into a 96-well plate
and incubated (5% CO2, 37°C). Afterward, the super-
natant was removed and different concentrations of
nanoliposomal artemisinin formulation and its control,
as well as pegylated nanoliposomal artemisinin formula-
tion and its control, in addition to standard artemisinin
was poured on cells; and then incubated for 24 hours on
mentioned conditions. After that the supernatant was re-
moved and 100 μl of MTT solution (0.5 mg/ml) was
added. After 3 hours of incubation, purple (as to the for-
mation of formazane) in was dissolved in live cells in
100 μl of isopropanol. Absorption was measured at wavein and pegylated nanoliposomal artemisinin for breast
Figure 2 Experimental vs predicted cytotoxicity for validation data of nanoliposomal drug.
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and IC50 was calculated by using Pharm program.Results and discussion
Size measurement of nanoliposomes
Mean diameter of nanoliposomal artemisinin was mea-
sured 500 nm and that of pegylated nanoliposomal arte-
misinin was 455 nm which was considered to be in nano
dimension size.Figure 3 Experimental vs predicted cytotoxicity for validation data ofEncapsulation efficiency
Encapsulation efficiency (EE %) was calculated through
spectrophotometry method. Regarding encapsulation ef-
ficiency formulation, the amount of nonencapsulated ar-
temisinin is obtained, which leads to determination of
the amount of encapsulated drug, considering the
amount of the initial drug. Encapsulation efficiency is
96.02% for nanoliposomal artemisinin formulation and
91.62% for pegylated nanoliposomal artemisinin
formulation.pegylated nanoliposomal drug.
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MTT technique was hired to obtain toxicity. IC50 for
nanoliposomal, pegylated nanoliposomal and standard
drug is 2.1, 1.58 and 2.7 μl/ml by means of Pharm
program.
Artificial neural networks
Artificial neural networks are characterized by network
architecture, node characteristics, and learning rules.
The operation of neural networks is divided into two
stages: learning (training) and generalization (recalling).
Network training is typically accomplished by using ex-
amples, and network parameters are adapted using a
learning method. This can be done in an online or
offline manner. Once the network is trained to accom-
plish the desired performance, the learning process is
terminated and it can then be used directly to replace
the complex system dynamics. The trained network can
be used to operate in a static manner: to simulate an un-
known dynamics or nonlinear relationship Arbib (2002).
Neural networks are usually biologically motivated. Each
neuron is a computational node, which represents a
nonlinear function. Most applications of neural networks
utilize the function approximation capability of neural
networks. These include modeling and system identifica-
tion, regression and prediction. The neural networks are
trained using supervised learning Feng and Ratnam
(2000). The input and output layers are defined
according to the dimensions of the input and output
patterns. The input–output pattern pairs are fed to the
network, and network parameters are adjusted accord-
ingly. A trained network represents the learned
nonlinear relation between the input–output pairs, and
can generalize when an unknown input pattern is
presented to the network Tipping (2001).
Artificial neural network modeling
In this study, cytotoxicity of artemisinin in breast cancer
treatment by means of feed-forward artificial neural net-
works is modeled and predicted. Thus, a three-layer
neural network is designed which incorporates 6 neu-
rons in hidden layer and one in input layer for drug con-
centration and one neuron in output layer for
cytotoxicity. Transfer function of Radbas is used for
hidden layer neurons and Purlin transfer function is
used for output layer; and Levevberg-marquardt
backpropagation algorithm was used as network training
procedure. Then, four sets of data including drug con-
centration and cytotoxicity are implemented to the net-
work. After the training stage, two sets of new data,
which have had no roles in network training, are
implemented to the network as input according to
Figure 1. And then, network output, including cytoto-
xicity, was anticipated.Figure 2 and Figure 3 reveal that neural network an-
ticipation and experimental values for cytotoxicity are
closely similar; in which network anticipation for cyto-
toxicity of nanoliposomal drug correlation of coefficient
is R = 0.9104 with a mean square error of 29.3837 and
that of pegylated nanoliposomal drug correlation of co-
efficient is R = 0.8925 with a mean square error of
37.0219.
Conclusion
This study shows that neural network can provide an ap-
propriate approach for drug cytotoxicity modeling and
anticipation. This approach can be employed for cyto-
toxicity and IC50 anticipation of anti cancer drugs with
very high accuracy.
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